John Harry Cross III - 06 Feb 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Financial Officer
Signature
/s/ John Harry Cross III
Issuer symbol
SONN
Transactions as of
06 Feb 2023
Net transactions value
-$2,078
Form type
4
Filing time
17 Feb 2023, 15:45:39 UTC
Previous filing
22 Dec 2022
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Tax liability $2,078 -1,960 -7.6% $1.06 23,927 06 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested restricted stock units.